Response to purine-containing compound

pathway activity — cross-omics
GO:0014074Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to purine-containing compound pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are SERPING1, SF3B3, and NID2, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to purine-containing compound activity versus SERPING1 in BRCA (Pearson r = 0.34).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCASERPING1 →+0.607+0.019<.001<.00139
OVSF3B3 →-0.254-0.033<.001.00139
UCECNID2 →+0.533+0.036.002<.00139
OVSNRPD2 →-0.443-0.041<.001<.00139
GBMTHRAP3 →-0.243-0.056<.001<.00139
GBMBCLAF1 →-0.297-0.056<.001<.00139
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014074 vs SERPING1 — BRCA

Per-sample scatter of Response to purine-containing compound activity vs SERPING1 in BRCA.

Explore this scatter interactively →

Exploration